In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

European Journal of Heart Failure

Advancing knowledge in the field of heart failure management

 

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Submit your paper

Fast Facts

  • Editor-in-Chief: Michael Böhm (DE)
  • Current volume: 27 (year 2025)
  • Issues per subscription: 12
  • Impact Factor 2023:  16.9

Editor-in-chief History

Name Start Date End Date
Professor John Cleland 01/01/1999 31/12/2004
Professor Karl Swedberg 01/01/2005 31/12/2009
Professor Dirk J. Van Veldhuisen 01/01/2010 31/12/2014
Professor Marco Metra 01/01/2015 31/03/2024
Professor Michael Böhm 01/04/2024  
Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.

Most recent articles from EJHF

14 Jan 2025
Association of a remote monitoring programme with all‐cause mortality and hospitalizations in patients with heart failure: National‐scale, real‐world evidence from a 3‐year propensity score analysis of the TELESAT‐HF study
Author(s): Nicolas Girerd, Vanessa Barbet, Marie‐France Seronde, Hélène Benchimol, Annabelle Jagu, Jean‐Michel Tartière, Olivier Hanon, François Picard, Stéphane Lafitte, Magali Lemaitre, Nicolas Pages, Sophie Nisse‐Durgeat, Patrick Jourdain
10 Jan 2025
Sacubitril/valsartan versus valsartan initiation in patients naïve to renin–angiotensin system inhibitors: Insights from PARAGLIDE‐HF
Author(s): Nina Nouhravesh, Alexander H. Gunn, Derek Cyr, Adrian F. Hernandez, David A. Morrow, Eric J. Velazquez, Jonathan H. Ward, Samiha Sarwat, Kavita Sharma, Kristin M. Williamson, Randall C. Starling, Serge Lepage, Shelley Zieroth, Scott D. Solomon, Robert J. Mentz
10 Jan 2025
Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial
Author(s): Ambarish Pandey, Ahmed A. Kolkailah, Darren K. McGuire, Robert C. Frederich, Nilo B. Cater, Francesco Cosentino, Richard E. Pratley, Samuel Dagogo‐Jack, David Z.I. Cherney, Willy Wynant, Ira Gantz, James P. Mancuso, Urszula Masiukiewicz, Christopher P. Cannon
10 Jan 2025
Aetiology and clinical manifestations of patients with non‐dilated left ventricular cardiomyopathy. Some comments
Author(s): Salvatore Chirumbolo